Showing results (11-20 of 877) with videos related to
Sort By:
Pageof 88
F1000Research|December 14, 2018
New hypoglycemic agents and the kidney: what do the major trials tell us?Brendan Smyth, Vlado PerkovicEuropean Heart Journal|October 15, 2008
Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trialsFiona Turnbull, Mark Woodward, Bruce Neal, et al.Diabetes & Vascular Disease Research|March 3, 2012
Effects of SGLT2 inhibitors on cardiovascular outcomesCeline Foote, Vlado Perkovic, Bruce NealDiabetes, Obesity & Metabolism|February 19, 2021
Variability in estimated glomerular filtration rate and the risk of major clinical outcomes in diabetes: Post hoc analysis from the ADVANCE trialMin Jun, Katie Harris, Hiddo J L Heerspink, et al.Clinical Journal of the American Society of Nephrology : CJASN|June 5, 2019
Combination of Changes in Estimated GFR and Albuminuria and the Risk of Major Clinical OutcomesToshiaki Ohkuma, Min Jun, John Chalmers, et al.Frontiers in Cardiovascular Medicine|May 5, 2022
A Novel Risk Prediction Model for Severe Acute Kidney Injury in Intensive Care Unit Patients Receiving Fluid ResuscitationYunlin Feng, Qiang Li, Simon Finfer, et al.Kidney International Reports|February 12, 2024
The Prevalence of CKD in Australian Primary Care: Analysis of a National General Practice DatasetMin Jun, James Wick, Brendon L Neuen, et al.Current Opinion in Nephrology and Hypertension|September 28, 2023
Combination therapy with kidney protective therapies: optimizing the benefits?Sradha Kotwal, Evan Perkovic, Vlado PerkovicContributions to Nephrology|June 11, 2011
Intensive glycemic control and renal outcomeMin Jun, Vlado Perkovic, Alan CassExpert Review of Clinical Pharmacology|August 1, 2022
Impact of SGLT2 inhibitors on the kidney in people with type 2 diabetes and severely increased albuminuriaNasir Shah, Vlado Perkovic, Sradha KotwalPageof 88